Silencing of CASC8 inhibits non-small cell lung cancer cells function and promotes sensitivity to osimertinib via FOXM1.
Cancer susceptibility candidate 8
Forkhead Box Protein M1
Long noncoding RNAs
Non-small Cell Lung
Osimertinib
Journal
Journal of Cancer
ISSN: 1837-9664
Titre abrégé: J Cancer
Pays: Australia
ID NLM: 101535920
Informations de publication
Date de publication:
2021
2021
Historique:
received:
07
05
2020
accepted:
25
10
2020
entrez:
4
1
2021
pubmed:
5
1
2021
medline:
5
1
2021
Statut:
epublish
Résumé
In a meta-analysis, the long noncoding RNA cancer susceptibility candidate 8
Identifiants
pubmed: 33391435
doi: 10.7150/jca.47863
pii: jcav12p0387
pmc: PMC7739000
doi:
Types de publication
Journal Article
Langues
eng
Pagination
387-396Informations de copyright
© The author(s).
Déclaration de conflit d'intérêts
Competing Interests: The authors have declared that no competing interest exists.
Références
Science. 2008 Dec 12;322(5908):1717-20
pubmed: 18988810
JAMA Oncol. 2015 Jul;1(4):505-27
pubmed: 26181261
Int J Cancer. 2014 May 15;134(10):2305-13
pubmed: 24174344
Semin Cancer Biol. 2014 Dec;29:32-9
pubmed: 25068996
N Engl J Med. 2010 Jun 24;362(25):2380-8
pubmed: 20573926
Lancet Oncol. 2011 Aug;12(8):735-42
pubmed: 21783417
J Biol Chem. 1996 Jan 5;271(1):595-602
pubmed: 8550625
Oncotarget. 2016 Jan 5;7(1):293-307
pubmed: 26588055
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32
pubmed: 26808342
Nat Cell Biol. 2000 Feb;2(2):76-83
pubmed: 10655586
Phytother Res. 2018 Sep;32(9):1755-1763
pubmed: 29722086
N Engl J Med. 2013 Jun 20;368(25):2385-94
pubmed: 23724913
EMBO J. 2013 Jan 23;32(2):231-44
pubmed: 23288041
JAMA Oncol. 2018 Nov 1;4(11):1527-1534
pubmed: 30073261
N Engl J Med. 2009 Sep 3;361(10):947-57
pubmed: 19692680
Cell Mol Life Sci. 2016 Jul;73(13):2491-509
pubmed: 27007508
Mol Cell. 2011 Sep 16;43(6):904-14
pubmed: 21925379
Nat Cell Biol. 2000 Feb;2(2):84-9
pubmed: 10655587
Nat Rev Cancer. 2007 Jun;7(6):415-28
pubmed: 17508028
Nature. 2010 Jun 24;465(7301):1033-8
pubmed: 20577206
Semin Cancer Biol. 2018 Oct;52(Pt 1):103-109
pubmed: 29183778
Genome Res. 2012 Sep;22(9):1646-57
pubmed: 22955977
Cancer Manag Res. 2018 Aug 31;10:3141-3148
pubmed: 30214306
Nat Genet. 2007 Aug;39(8):1033-7
pubmed: 17643101
Cell Physiol Biochem. 2018;49(2):816-827
pubmed: 30165346
Clin Cancer Res. 2011 Mar 15;17(6):1616-22
pubmed: 21135146
Lancet Oncol. 2014 Feb;15(2):213-22
pubmed: 24439929
Cancer Res. 2017 Jun 15;77(12):3135-3139
pubmed: 28584182
Cell Prolif. 2019 Jul;52(4):e12617
pubmed: 31012173
Nat Commun. 2017 Mar 13;8:14768
pubmed: 28287083
Curr Opin Genet Dev. 2005 Feb;15(1):42-8
pubmed: 15661532
Sci Signal. 2010 Feb 02;3(107):ra8
pubmed: 20124551
JAMA Oncol. 2018 Aug 1;4(8):1080-1084
pubmed: 29852038
Acta Pharmacol Sin. 2012 May;33(5):675-81
pubmed: 22447226
Lung Cancer. 2017 Jul;109:9-13
pubmed: 28577957
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Cancer Lett. 2018 Apr 28;420:242-246
pubmed: 29425688
Cell. 2013 Jul 3;154(1):240-51
pubmed: 23810193
Int J Biol Sci. 2015 Jan 05;11(2):186-98
pubmed: 25561901